Related Experiment Video
Updated: Jun 6, 2026
12:28
Abbiategrasso Brain Bank Protocol for Collecting, Processing and Characterizing Aging Brains
Published on: June 3, 2020
Biogerontology in Finland
Timo E Strandberg1, Sarianna Sipilä
1Institute of Health Sciences/Geriatrics, Oulu University Hospital, University of Oulu, Oulu, Finland. timo.strandberg@oulu.fi
Biogerontology
|December 17, 2010
Summary
This paper reviews current biogerontology research in Finland, focusing on genetics, aging mechanisms, and age-related diseases like neurodegeneration. It highlights key university research and international collaborations in aging science.
Area of Science:
- Biogerontology
- Aging Research
- Geriatrics
Background:
- Finland's gerontology research landscape is evolving.
- Understanding the basic mechanisms of aging is crucial for addressing age-related diseases.
Purpose of the Study:
- To describe current biogerontology research activities in Finnish universities.
- To highlight key research areas and international collaborations in the field.
Main Methods:
- Review of research at Finnish universities with gerontology/geriatrics professorships.
- Analysis of prevalent research topics including genetics, mitochondrial function, musculoskeletal physiology, neurodegenerative, and vascular diseases.
- Brief description of research activities and international collaborations, with examples from recent publications.
Main Results:
- Key research areas include basic genetics, mitochondrial function, musculoskeletal health, and neurodegenerative/vascular diseases.
- Significant international collaborations are active in Finnish biogerontology research.
- Recent publications showcase advancements in understanding normal aging and age-related conditions.
Conclusions:
- Finnish biogerontology research is active and diverse, covering fundamental aging processes and age-related pathologies.
- International collaboration strengthens research output and impact.
- The field is contributing significantly to the understanding of aging and its associated diseases.
More Related Videos
Related Concept Videos
01:26Aging
Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
01:19The Effect of Aging on Tissues
Several body functions deteriorate with age. The external signs of aging are easily identifiable. For example, the skin becomes dry, less elastic, and thins out, forming wrinkles. The skin of the face begins to appear looser due to a decrease in the levels of elastic and collagen fibers in the connective tissue. Additionally, melanin production in the hair follicle decreases with age, resulting in gray hair. Moreover, the senses of sight and hearing decline, so glasses and hearing aids may...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...